OBJECTIVE: To determine the incidence of most significant radiological findings of paracoccidioidomycosis and to verify its possible variants. MATERIALS AND METHODS: One hundred and seventy-three cases of paracoccidioidomycosis presented between 1970 and 1980 were reviewed, including their radiological workup reanalysis by at least two experienced radiologists.RESULTS: Ninety-four cases were pulmonary only and 38 were pulmonary associated with ganglial, visceral and osseous lesions or in association with tuberculosis. There was no pulmonary involvement in 41 cases, with small bowel, viscera, bone lesions, or a combination of these. Most significant radiological findings in cases of pulmonary involvement were bilateral, diffuse reticular and nodular interstitial infiltrate, followed by the diffuse bilateral alveolar form. Visceral and gastrointestinal tract lesions presented predominantly with liver, jejunum and ileum involvement.Lymph nodal involvement was predominantly diffuse, abdominal or peripheral. In bones, osteolytic lesions affected predominantly long bones and clavicle. CONCLUSION: Paracoccidioidomycosis is a granulomatous disease commonly found in Brazil, primarily affecting lungs, caused by inhalation of fungus spores. Other rare or less frequent forms of the disease should be taken into consideration for differential diagnosis.
Inferior vena cava anomalies are rare, occurring in up to 8.7% of the population, as left renal vein anomalies are considered. The inferior vena cava develops from the sixth to the eighth gestational weeks, originating from three paired embryonic veins, namely the subcardinal, supracardinal and postcardinal veins. This complex ontogenesis of the inferior vena cava, with multiple anastomoses between the pairs of embryonic veins, leads to a number of anatomic variations in the venous return from the abdomen and lower limbs. Some of such variations have significant clinical and surgical implications related to other cardiovascular anomalies and in some cases associated with venous thrombosis of lower limbs, particularly in young adults. The authors reviewed images of ten patients with inferior vena cava anomalies, three of them with deep venous thrombosis. The authors highlight the major findings of inferior vena cava anomalies at multidetector computed tomography and magnetic resonance imaging, correlating them the embryonic development and demonstrating the main alternative pathways for venous drainage. The knowledge on the inferior vena cava anomalies is critical in the assessment of abdominal images to avoid misdiagnosis and to indicate the possibility of associated anomalies, besides clinical and surgical implications.
In chronic Chagas disease, RV systolic dysfunction is more commonly associated with left ventricular systolic dysfunction, although isolated and early RV dysfunction can also be identified.
BackgroundCardiac tumors are extremely rare; however, when there is clinical suspicion,
proper diagnostic evaluation is necessary to plan the most appropriate treatment.
In this context, cardiovascular magnetic resonance imaging (CMRI) plays an
important role, allowing a comprehensive characterization of such lesions.ObjectiveTo review cases referred to a CMRI Department for investigation of cardiac and
paracardiac masses. To describe the positive case series with a brief review of
the literature for each type of lesion and the role of cardiovascular magnetic
resonance imaging in evaluation.MethodsBetween August 2008 and December 2011, all cases referred for CMRI with suspicion
of tumor involving the heart were reviewed. Cases with positive histopathological
diagnosis, clinical evolution or therapeutic response compatible with the clinical
suspicion and imaging findings were selected.ResultsAmong the 13 cases included in our study, eight (62%) had histopathological
confirmation. We describe five benign tumors (myxomas, rhabdomyoma and fibromas),
five malignancies (sarcoma, lymphoma, Richter syndrome involving the heart and
metastatic disease) and three non-neoplastic lesions (pericardial cyst,
intracardiac thrombus and infectious vegetation).ConclusionCMRI plays an important role in the evaluation of cardiac masses of non-neoplastic
and neoplastic origin, contributing to a more accurate diagnosis in a noninvasive
manner and assisting in treatment planning, allowing safe clinical follow-up with
good reproducibility.
ObjectiveTo propose a protocol for pulmonary angiography using 64-slice multidetector
computed tomography (64-MDCT) with 50 mL of iodinated contrast material, in
an unselected patient population, as well as to evaluate vascular
enhancement and image quality.Materials and MethodsWe evaluated 29 patients (22-86 years of age). The body mass index ranged
from 19.0 kg/m2 to 41.8 kg/m2. Patients underwent
pulmonary CT angiography in a 64-MDCT scanner, receiving 50 mL of iodinated
contrast material via venous access at a rate of 4.5 mL/s. Bolus tracking
was applied in the superior vena cava. Two experienced radiologists assessed
image quality and vascular enhancement.ResultsThe mean density was 382 Hounsfield units (HU) for the pulmonary trunk; 379
and 377 HU for the right and left main pulmonary arteries, respectively; and
346 and 364 HU for the right and left inferior pulmonary arteries,
respectively. In all patients, subsegmental arteries were analyzed. There
were streak artifacts from contrast material in the superior vena cava in
all patients. However, those artifacts did not impair the image
analysis.ConclusionOur findings suggest that pulmonary angiography using 64-MDCT with 50 mL of
iodinated contrast can produce high quality images in unselected patient
populations.
scite is a Brooklyn-based startup that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.